|
Pharmaceutical Executive
Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.
On the "Pharm Exec" blog.(On the Web)
October 01, 2008
Quotables.(Leading Indicators News)
October 01, 2008
Getting "personalized": sure, there are reasons why personalized medic...
October 01, 2008
Stop the bleeding: a prescription for rebate validations.
October 01, 2008
Mexico: climbing to the top of the pyramid.(Mexico Report)(Industry ov...
October 01, 2008
Getting 'engaged': web analytics can help a new generation of pharmace...
October 01, 2008
Medpoint Communications.(People)
October 01, 2008
inVentiv Health.(People)
October 01, 2008
Dori Stowe.(People)
October 01, 2008
Topin & Associates.(People)
October 01, 2008
HC&B Healthcare Communications.(People)
October 01, 2008
Julie Deel.(People)
October 01, 2008
John W. Draper.(People)
October 01, 2008
Concentric Pharma Advertising.(People)
October 01, 2008
Medical Affairs Company.(People)
October 01, 2008
Allen Stegall.(People)
October 01, 2008
CommonHealth.(People)
October 01, 2008
Events.(Calendar)
October 01, 2008
The drug vote '08: a head-to-head analysis of the two brands.(Back Pag...
October 01, 2008
Branding under fire: between Congress, the courts, and consumers, DTC ...
October 01, 2008
Seasoned leaders: assessing key opinion leader management requires a c...
October 01, 2008
Remodeling your sales force: transitioning to a decentralized sales fo...
October 01, 2008
Evolutionary branding: a DTC backlash is forcing branders to come up w...
October 01, 2008
Detailing Dr. House: promotion or risky prescribing? Dr. House, the le...
October 01, 2008
Pharmaceutical product placements: the next DTC? Drugs are being menti...
October 01, 2008
Maximize your brand: uncovering growth opportunities: with an updated ...
October 01, 2008
Lifecycle management planning for yesterday: what companies need is a ...
October 01, 2008
What's the buzz? A compelling word-of-mouth campaign creates an elemen...
October 01, 2008
Listen up!(On the Web)
October 01, 2008
What they're saying ...(Leading Indicators: People + events + ideas th...
October 01, 2008
Will FDA finalize off-label reprint guidance? Congressional opposition...
October 01, 2008
A night to remember: the drug industry takes a moment to recognize it'...
October 01, 2008
Evolving clinical trials: the process of developing drugs needs to cha...
October 01, 2008
Chemical rules leave pharma pondering: a primer on what to expect from...
October 01, 2008
Academy-industry ties under fire: research institutions curbing pharma...
October 01, 2008
Part D under attack: congressional leaders ready campaign to curb priv...
October 01, 2008
Open for debate: tensions mount as stakeholders in the UK health indus...
October 01, 2008
Specialty sales gets no resistance.(RESISTANCE FIGHTER: MICHAEL BONNEY...
October 01, 2008
Going for gold: handling a multitude of mundane tasks at one sitting c...
October 01, 2008
The D-mab men: Amgen's future lies in the hands of denosumab lead inve...
October 01, 2008
Global warming: the Japanese Pharma League has spent almost $50 billio...
October 01, 2008
Future shock: a vision of pharma's next business model is starting to ...
October 01, 2008
Analyzed in "Pharm Exec Direct".(On the Web)
October 01, 2008
No CAP for Medicare drugs: CMS announces two-year hiatus for cancer an...
October 01, 2008
Sample sales: generics up sans samples.(SAMPLING)(Brief article)
October 01, 2008
Plug in to the buzz: marketing to physicians in the New Media landscap...
October 01, 2008
How to manage a winning agency relationship: pharma is looking to adve...
October 01, 2008
Is bigger better? Expansion of preapproval clinical trials should be w...
October 01, 2008
Garnier takes the reigns: executive shuffle causes a stir overseas.(PE...
October 01, 2008
Room to improve: benefit execs list preferred fixes.(CONGRESS)
October 01, 2008
Leading indicators: people + events + ideas that are shaping pharma's ...
October 01, 2008
|